跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROBITUSSIN PS SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
ROBITUSSIN PS SYRUP
Approved
THERAPEUTIC
ROBITUSSIN PS SYRUP
INTERPHIL LABORATORIES INC
🇸🇬 Health Sciences Authority
Approval Date
Mar 7, 2003
Approval ID
b2e48146a9149de0
Company
INTERPHIL LABORATORIES INC
Type
Therapeutic
Approval Details
Approval Id
b2e48146a9149de0
Drug Name
ROBITUSSIN PS SYRUP
Product Name
ROBITUSSIN PS SYRUP
Approval Number
SIN12223P
Approval Date
2003-03-07
Registrant
GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Licence Holder
GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CA10
Atc Item Name
combinations
Pharma Manufacturer Name
gsk consumer healthcare singapore pte. ltd.
Active Ingredients
PSEUDOEPHEDRINE HCl
60 mg/10 ml
GUAIPHENESIN
200 mg/10 ml
GUAIPHENESIN
200 mg/10 ml
PSEUDOEPHEDRINE HCl
60 mg/10 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 7, 2003
Approval ID
b2e48146a9149de0
Type
Therapeutic
Back to HSA Approvals